Stock-Based Compensation | 6 Months Ended |
Jul. 01, 2014 |
Stock-Based Compensation | ' |
4 | Stock-Based Compensation | | | | | | | | | | | | | | | |
As of July 1, 2014, the Company had three active stock-based compensation plans: the 2011 Omnibus Incentive Plan (the “Omnibus Plan”), the Equity Plan for Non-Employee Directors (the “Equity Plan”) and the Stock Appreciation Rights Plan (the “SARs Plan”). Outstanding awards previously issued under inactive or suspended plans will continue to vest and remain exercisable in accordance with the terms of the respective plans. On April 29, 2014, the Company’s shareholders approved an increase of 850,000 shares to be issued under the Omnibus Plan. As of July 1, 2014, there were 970,601 shares, 69,088 shares and 115,493 shares reserved for issuance pursuant to future awards under the Omnibus Plan, the Equity Plan and the SARs Plan, respectively. |
The Company’s stock-based compensation cost for the thirteen weeks ended July 2, 2013 and July 1, 2014 was approximately $0.5 million and $0.6 million, respectively. The Company’s stock-based compensation costs for the twenty-six weeks ended July 2, 2013 and July 1, 2014 was $1.1 million and $1.5 million, respectively. These costs are normally included in general and administrative expenses. For the thirteen weeks and twenty-six weeks ended July 1, 2014, the Company recorded $0.3 million and $0.7 million, respectively, in stock based compensation costs as “Management transition and related reorganization expenses” as these costs are direct and incremental to the departure of certain members of management. Compensation cost for stock options and stock appreciation rights (“SARs”) granted is based on the fair value of each award, measured by applying the Black-Scholes model on the date of grant, using the following assumptions: |
|
| | | | | | | | | | | | | | | | |
| | 13 weeks ended | | | 26 weeks ended | |
| | July 2, | | | July 1, | | | July 2, | | | July 1, | |
| | 2013 | | | 2014 | | | 2013 | | | 2014 | |
Expected life of options and SARs from date of grant | | | 3.25-6.0 years | | | | 3.25 years | | | | 3.25-6.0 years | | | | 2.75-6.0 years | |
Risk-free interest rate | | | 0.34%-1.46% | | | | 0.88% | | | | 0.34%-1.46% | | | | 0.69%-1.84% | |
Volatility | | | 30% | | | | 28% | | | | 30%-32% | | | | 28%-29% | |
Assumed dividend yield | | | 3.35% | | | | 3.21% | | | | 3.35%-3.48% | | | | 3.15%-3.21% | |
|
Stock Option and SARs Activity |
Stock option and SARs transactions under all plans during the twenty-six weeks ended July 1, 2014 were as follows: |
|
| | | | | | | | | | | | | | | | |
| | Number of | | | Weighted | | | Weighted Average | | | | | |
Options | Average | Remaining Life | | | | |
and SARs | Exercise Price | (Years) | | | | |
Outstanding, December 31, 2013 | | | 1,214,424 | | | $ | 11.46 | | | | | | | | | |
Granted | | | 120,083 | | | | 14.52 | | | | | | | | | |
Exercised | | | (395,981 | ) | | | 10.55 | | | | | | | | | |
Forfeited/Cancelled | | | (68,889 | ) | | | 13.66 | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Outstanding, July 1, 2014 | | | 869,637 | | | $ | 12.13 | | | | 6.29 | | | | | |
| | | | | | | | | | | | | | | | |
Exercisable and vested, July 1, 2014 | | | 603,155 | | | $ | 11.18 | | | | 5.41 | | | | | |
| | | | | | | | | | | | | | | | |
The aggregate intrinsic value of stock options exercised during the twenty-six weeks ended July 1, 2014 was $2.2 million. |
As of July 1, 2014, the Company had approximately $0.4 million of total unrecognized compensation cost related to stock option and SARs awards granted under its plans, which will be recognized over a weighted average period of 1.35 years. |
Restricted Stock Units |
Stock-based compensation cost for restricted stock units (“RSUs”) is measured based on the closing fair market value of the Company’s common stock on the date of grant. Transactions during the twenty-six weeks ended July 1, 2014 were as follows: |
|
| | | | | | | | | | | | | | | | |
| | Number | | | Weighted Average | | | | | | | | |
| | of | | | Grant Date | | | Aggregate | | | | | |
| | Shares | | | Fair Value | | | Intrinsic Value | | | | | |
Non-vested rights, December 31, 2013 | | | 156,356 | | | $ | 14.33 | | | | | | | | | |
Granted | | | 140,875 | | | | 14.58 | | | | | | | | | |
Vested | | | (105,860 | ) | | | 14.27 | | | | | | | | | |
Forfeited | | | (28,447 | ) | | | 14.19 | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Non-vested rights, July 1, 2014 | | | 162,924 | | | $ | 14.61 | | | $ | 2,564,300 | | | | | |
| | | | | | | | | | | | | | | | |
As of July 1, 2014, the Company had approximately $1.4 million of total unrecognized compensation cost related to RSUs, which will be recognized over a weighted average period of 1.29 years. |